FDA approves Progenics’ Azedra

Aug 03, 2018 , Drug Store News - Retail

Azedra is the first FDA-approved drug for treating adults and adolescents age 12 years old and older with rare adrenal tumors, according to Progenics Pharmaceuticals.

Read More

Read the full story...

Trending healthcare news keywords at this moment

blood type study brain drug diabetes time risk death prevent million cases heart linked care opioid medical abortion fda approval tied patients outbreak life doctors weight vaccine shows young kids tip research state medicaid medicare high company cancer people uganda ebola ways back report cdc fecal